Kiromic Biopharma, Inc. Increase (Decrease) in Accounts Receivable
Kiromic Biopharma, Inc. reported Increase (Decrease) in Accounts Receivable of -$16.20 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2024-03-19
- Kiromic Biopharma, Inc. increase (decrease) in accounts receivable for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Kiromic Biopharma, Inc. increase (decrease) in accounts receivable for the quarter ending 2022-09-30 was $0.00.
- Kiromic Biopharma, Inc. increase (decrease) in accounts receivable for the quarter ending 2022-06-30 was $0.00.
- Kiromic Biopharma, Inc. increase (decrease) in accounts receivable for the quarter ending 2022-03-31 was -$16.20K.
- Kiromic Biopharma, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$16.20K.
- Kiromic Biopharma, Inc. increase (decrease) in accounts receivable for fiscal 2021 was -$9.80K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $0.00 derived: sum of 3 quarters · filed 2024-03-19 | -$16.20K 10-K · filed 2024-03-19 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | -$16.20K 10-Q · filed 2023-11-14 | -$5.80K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$16.20K 10-Q · filed 2023-08-14 | -$5.80K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$16.20K 10-Q · filed 2023-05-15 | -$5.80K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $10.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$9.80K 10-K · filed 2023-04-17 | ||
| 2021-09-30 | -$20.20K 10-Q · filed 2022-11-14 |